In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

A novel coronavirus, named SARS-CoV-2, emerged in 2019 in China and rapidly spread worldwide. As no approved therapeutics exists to treat COVID-19, the disease associated to SARS-Cov-2, there is an urgent need to propose molecules that could quickly enter into clinics. Repurposing of approved drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Touret, Franck, Gilles, Magali, Barral, Karine, Nougairède, Antoine, van Helden, Jacques, Decroly, Etienne, de Lamballerie, Xavier, Coutard, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403393/
https://www.ncbi.nlm.nih.gov/pubmed/32753646
http://dx.doi.org/10.1038/s41598-020-70143-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403393/
https://www.ncbi.nlm.nih.gov/pubmed/32753646
http://dx.doi.org/10.1038/s41598-020-70143-6

Ejemplares similares